Abstract:Purpose: Misdiagnosis and ineffective treatment are common in major depressive disorder (MDD) in current clinical practice, while the combination of various serum proteins may assist the correct diagnosis. The study aimed to explore whether the combination of serum inflammatory, stress, and neurotrophic factors could be helpful for the diagnosis of MDD and to investigate the predictors associated with early symptom improvements. Patients and Methods: Baseline serum levels of C-reactive protein (CRP), interleukin (IL)-6, IL-10, IL-1beta, tumor necrosis factor (TNF)-alpha, interferon (INF)-gamma, cortisol, and brain-derived neurotrophic factor (BDNF) were detected in 30 MDD patients and 30 age-and gender-matched healthy controls. 17-item Hamilton Depression Rating Scale (HAMD-17) and Hamilton Anxiety Rating Scale (HAMA) were applied to assess symptoms both at baseline and two weeks after antidepressant treatment. Stepwise multiple linear regression was employed to identify the early efficacy predictors, and a logistic regression model was built with the above serum proteins. The area under the receiver operating characteristic (AUC) curve was calculated to evaluate the model's diagnostic power. Results: Multiple linear regression revealed that baseline scores of retardation (beta = -0.432, P = 0.012) and psychological anxiety (beta = -0.423, P = 0.014) factors were negatively associated with the reduction rate of HAMD-17. A simple and efficient diagnostic model using serum BDNF, cortisol, and IFN-gamma levels was established by the forward stepwise logistic regression, and the model achieved an AUC of 0.884, with 86.7% sensitivity and 83.3% specificity. Conclusion: The results showed that combining serum BDNF, cortisol and IFN-gamma could aid the diagnosis of MDD, while baseline retardation and psychological anxiety may predict the poor early symptom improvement.

The Diagnostic Performance of the L-tryptophan/competing Amino Acids Ratio in Major Depression.

Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression.

The Decreased Availability of L-tryptophan in Depressed Females: Clinical and Biological Correlates

Increased Plasma Levels of Competing Amino Acids, Rather Than Lowered Plasma Tryptophan Levels, Are Associated with a Non-Response to Treatment in Major Depression.

Relationships Between Lower Plasma L-tryptophan Levels and Immune-Inflammatory Variables in Depression

Lower Serum L-Tryptophan Availability in Depression As a Marker of a More Generalized Disorder in Protein Metabolism

Serotonin-immune Interactions in Major Depression: Lower Serum Tryptophan As a Marker of an Immune-Inflammatory Response

Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients.

Symptom Profiles of Biological Markers in Depression: a Multivariate Study.

Significantly Increased Urinary Free Cortisol Excretion in Melancholic Depressed Females During L‐tryptophan Loading

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder

Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading

Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients.

The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients

The Relationships Between The Cortisol Responses To Dexamethasone And To L-5-Htp, And The Availability Of L-Tryptophan In Depressed Females

A Sensitive and Practical RP-HPLC-FLD for Determination of the Low Neuroactive Amino Acid Levels in Body Fluids and Its Application in Depression

The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder

Hypothalamic‐pituitary‐adrenal and ‐thyroid Axis Dysfunctions and Decrements in the Availability of L‐tryptophan As Biological Markers of Suicidal Ideation in Major Depressed Females

L-5-Hydroxytryptophan Stimulated Cortisol Escape from Dexamethasone Suppression in Melancholic Patients

Serum Levels of Excitatory Amino Acids, Serine, Glycine, Histidine, Threonine, Taurine, Alanine and Arginine in Treatment‐resistant Depression: Modulation by Treatment with Antidepressants and Prediction of Clinical Responsivity

Stimulatory Effects of L-5-Hydroxytryptophan on Postdexamethasone Β-Endorphin Levels in Major Depression